Nucleai Appoints Vikas Ahuja as VP of Strategic Partnerships
Vikas Ahuja brings over 20 years of strategic business experience in the life sciences industry from Quest Diagnostics, Ambry Genetics and Mallinckrodt Pharmaceuticals Nucleai, a...
Category : Biomarkers
Fountain Life Introduced Fountain Life CORE
Fountain Life CORE provides a recurring, comprehensive, longevity-focused blood panel paired with expert analysis and ongoing guidance from a Fountain Life longevity physician and health...
Beckman Coulter and MeMed to Advance Host Immune Response Diagnostics
Beckman Coulter Now an Authorized Distributor of MeMed Key Immunoassay System and MeMed BV Assay Progress Continues on Original Collaboration to Develop a MeMed BV-Based Assay...
Imaging Endpoints Unveils New Initiative with Revolution Endpoints™
Imaging Endpoints (IE), a global leader in Imaging CRO technologies and services, has announced the formation of a new subsidiary, Revolution Endpoints, focused on leveraging...
Nucleai and GoPath Diagnostics announce strategic collaboration
Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic...
Ambry Genetics announces a collaboration with Tempus
Ambry Genetics (Ambry), a leader in clinical diagnostic testing, and Tempus, a leader in artificial intelligence and precision medicine, announced today that they have entered into a...
Paige expands AppLab Marketplace with 6 new Digital Pathology Providers
Paige deepens its AppLab’s offerings by partnering with industry-leading third-party AI providers Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications...
Sapiens and Binah.ai announced partnership
The partnership will enable insurers to leverage health and wellness monitoring technology for streamlined underwriting and enhanced user experience Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS),...
Enhanc3D Genomics appoints Dr Daniel Turner as CSO
Appointment forms part of ongoing plans for continued development of the GenLink3D genomics platform and formation of strategic commercial and academic partnerships Enhanc3D Genomics, a company...
Genialis and Debiopharm set up biomarker discovery collaboration
Agreement allows both companies to define biomarkers within the DNA Damage Repair (DDR) biology space Genialis, the RNA-biomarker company, and Debiopharm, a privately-owned, Swiss-based biopharmaceutical...